Aurinia Pharmaceuticals Inc. (AUPH) vs Establishment Labs Holdings Inc. (ESTA)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Establishment Labs Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AUPH vs ESTA

growth of $100 · dividends reinvested · last 8y
AUPH +175.8% (+13.5%/yr)ESTA +168.6% (+13.1%/yr)AUPH compounded faster over this window
200400600Start $1002020202220242026$276$269
AUPH ESTA

AUPH vs ESTA: by the numbers

  • •AUPH is the larger company ($2.03B vs $1.97B market cap).
  • •AUPH is profitable (100.84% net margin) while ESTA runs a net loss (-15.82%).
  • •AUPH grew revenue faster over the past five years (40.17% vs 17.02% CAGR).

Metrics side by side

Valuation

MetricAUPHESTA
P/E ratio6.89N/A
Forward P/E16.71N/A
P/S ratio6.518.03
P/B ratio3.3091.33
EV / EBITDA11.22N/A
FCF yield8.56%N/A

Profitability

MetricAUPHESTA
Gross margin90.36%70.49%
Operating margin37.06%-18.48%
Net margin100.84%-15.82%
ROE51.09%-179.99%
ROIC21.77%-6.53%

Growth (annualized)

MetricAUPHESTA
Revenue CAGR (5Y)40.17%17.02%
Total return CAGR (5Y)-5.88%-1.56%

Frequently asked

Which has grown faster, AUPH or ESTA?
Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus ESTA at 17.02%.
Is AUPH or ESTA more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus ESTA at -15.82%.
How have AUPH and ESTA total returns compared?
Over the past 5 years, AUPH delivered -5.88% and ESTA delivered -1.56% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.